parecoxib has been researched along with montelukast sodium in 1 studies
| Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (montelukast sodium) | Trials (montelukast sodium) | Recent Studies (post-2010) (montelukast sodium) |
|---|---|---|---|---|---|
| 436 | 186 | 229 | 17 | 0 | 12 |
| Protein | Taxonomy | parecoxib (IC50) | montelukast sodium (IC50) |
|---|---|---|---|
| hypothetical protein SA1422 | Staphylococcus aureus subsp. aureus N315 | 13.39 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.1562 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heitel, P; Kalinowsky, L; Merk, D; Proschak, E | 1 |
1 review(s) available for parecoxib and montelukast sodium
| Article | Year |
|---|---|
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.
Topics: Animals; Cyclooxygenase Inhibitors; Drug Discovery; Fatty Acids; Humans; Inflammation; Models, Molecular | 2017 |